Submitted by Anonymous (not verified) on 7 November 2023 - 12:12
Human medicines European public assessment report (EPAR): Opsumit, macitentan, Hypertension, Pulmonary, Date of authorisation: 20/12/2013, Revision: 23, Status: Authorised
Source: